Ovarian Carcinoma
📧 Sign up to get email alerts when something new happens for Ovarian Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. [Phase 1]
Phase 1 study of PF-07826390 in cancer patients, including non-small cell lung cancer, was terminated; the trial evaluated different doses o…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors [Phase 2]
Phase 2 clinical trial of TJ004309 in combination with atezolizumab (TECENTRIQ) for ovarian cancer and selected solid tumors has completed e…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial update of sapanisertib with ziv-aflibercept in patients with recurrent, metastatic, or unresectable solid tumors, including fi…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors [Phase 1]
Pfizer's PF-07820435 study in advanced solid tumors, including non-small-cell lung cancer and other indications, has been terminated at Phas…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 trial of NM32-2668 in adults with selected advanced solid tumors has been terminated. The study enrolled multiple tumor types incl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002) [Phase 2]
Phase 2 trial MK-4830-002 evaluating pembrolizumab with chemotherapy and MK-4830 in ovarian cancer has completed enrollment with results pos…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of Maplirpacept in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer was terminated, …
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study of PF-07209960 in advanced or metastatic solid tumors was terminated, with results posted in July 2024.
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
A completed clinical trial update examining factors influencing cascade genetic testing among women with hereditary gynecologic cancers and …
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors [Phase 2]
A Phase 2 clinical trial evaluating dalpiciclib in combination with letrozole for recurrent ovarian carcinoma in HR+/HER2-negative gynecolog…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults [Phase 4]
Phase 4 clinical trial update assessing optimal dosing of oral anticancer drugs in older adults, with multiple cancer indications listed.
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) [Phase 3]
Phase 3 evaluation of adding AL3818 to standard platinum-based chemotherapy for recurrent or metastatic gynecologic carcinomas is in progres…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression [Phase 2]
A phase 2 trial comparing regorafenib to tamoxifen in platinum-sensitive ovarian carcinoma with isolated biological progression has complete…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of Folatescan (Technetium TC 99M EC20) in patients with suspected ovarian carcinom…
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission [Phase 1, Phase 2]
Phase 1/2 trial evaluating CDX-1401, Poly ICLC, and INCB024360 in remission for ovarian, fallopian tube, or primary peritoneal cancer comple…
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy [EARLY_Phase 1]
Early-phase pilot trial of denosumab in BRCA1/2 mutation carriers scheduled for risk-reducing salpingo-oophorectomy was terminated.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Niraparib Plus Anlotinib for Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating niraparib plus anlotinib for recurrent ovarian cancer; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating albumin-bound paclitaxel in combination with bevacizumab for platinum-resistant recurrent ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer [Phase 3]
Phase 3 trial evaluating symptom benefit rate of trabectedin plus pegylated liposomal doxorubicin (PLD) in recurrent ovarian cancer was term…
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating pemetrexed and carboplatin for recurrent ovarian, primary peritoneal, or fallopian tube cancer has complet…
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer [Phase 2]
Phase II study of Intraperitoneal NanoPac in ovarian cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies [Phase 2]
Phase 2 clinical trial of selinexor (KPT-330) in female patients with advanced gynecologic malignancies has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma [Phase 2]
A Phase 2 trial evaluating chemotherapy in ovarian, fallopian tube, and peritoneal carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab, bevacizumab, and cyclophosphamide in recurrent ovarian, fallopian tube, or primary peritone…
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of everolimus and letrozole in patients with recurrent hormone receptor-positive ovarian…